TY - JOUR
T1 - Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation
AU - Narula, Mansi
AU - Lakshmanan, Uma
AU - Borna, Simon
AU - Schulze, Janika J.
AU - Holmes, Tyson H.
AU - Harre, Nicholas
AU - Kirkey, Matthew
AU - Ramachandran, Akshaya
AU - Tagi, Veronica Maria
AU - Barzaghi, Federica
AU - Grunebaum, Eyal
AU - Upton, Julia E.M.
AU - Hong-Diep Kim, Vy
AU - Wysocki, Christian
AU - Dimitriades, Victoria R.
AU - Weinberg, Kenneth
AU - Weinacht, Katja G.
AU - Gernez, Yael
AU - Sathi, Bindu K.
AU - Schelotto, Magdalena
AU - Johnson, Matthew
AU - Olek, Sven
AU - Sachsenmaier, Christoph
AU - Roncarolo, Maria Grazia
AU - Bacchetta, Rosa
N1 - Funding Information:
R.B. is an Anne T. and Robert M. Bass Faculty Scholar of the Department of Pediatrics, Stanford University School of Medicine. This work has been largely supported by the Bonnie Uytengsu and family endowment for the Center for Genetic Immune Diseases and the Center for Definitive and Curative Medicine, and by a gift from the Lucile Packard Foundation for Children's Health. V.T. is in the Pediatric Residency Program at Chieti University, Italy. Additional support came from the MCHRI New Idea grant and SPARK awards to R.B.
Funding Information:
R.B. is an Anne T. and Robert M. Bass Faculty Scholar of the Department of Pediatrics, Stanford University School of Medicine. This work has been largely supported by the Bonnie Uytengsu and family endowment for the Center for Genetic Immune Diseases and the Center for Definitive and Curative Medicine, and by a gift from the Lucile Packard Foundation for Children’s Health. V.T. is in the Pediatric Residency Program at Chieti University, Italy. Additional support came from the MCHRI New Idea grant and SPARK awards to R.B.
Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Background: Forkhead box protein 3 (FOXP3) is the master transcription factor in CD4+CD25hiCD127lo regulatory T (Treg) cells. Mutations in FOXP3 result in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Clinical presentation of IPEX syndrome is broader than initially described, challenging the understanding of the disease, its evolution, and treatment choice. Objective: We sought to study the type and extent of immunologic abnormalities that remain ill-defined in IPEX, across genetic and clinical heterogeneity. Methods: We performed Treg-cell–specific epigenetic quantification and immunologic characterization of severe “typical” (n = 6) and “atypical” or asymptomatic (n = 9) patients with IPEX. Results: Increased number of cells with Treg-cell–Specific Demethylated Region demethylation in FOXP3 is a consistent feature in patients with IPEX, with (1) highest values in those with typical IPEX, (2) increased values in subjects with pathogenic FOXP3 but still no symptoms, and (3) gradual increase over the course of disease progression. Large-scale profiling using Luminex identified plasma inflammatory signature of macrophage activation and TH2 polarization, with cytokines previously not associated with IPEX pathology, including CCL22, CCL17, CCL15, and IL-13, and the inflammatory markers TNF-α, IL-1A, IL-8, sFasL, and CXCL9. Similarly, both Treg-cell and Teff compartments, studied by Mass Cytometry by Time-Of-Flight, were skewed toward the TH2 compartment, especially in typical IPEX. Conclusions: Elevated TSDR-demethylated cells, combined with elevation of plasmatic and cellular markers of a polarized type 2 inflammatory immune response, extends our understanding of IPEX diagnosis and heterogeneity.
AB - Background: Forkhead box protein 3 (FOXP3) is the master transcription factor in CD4+CD25hiCD127lo regulatory T (Treg) cells. Mutations in FOXP3 result in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Clinical presentation of IPEX syndrome is broader than initially described, challenging the understanding of the disease, its evolution, and treatment choice. Objective: We sought to study the type and extent of immunologic abnormalities that remain ill-defined in IPEX, across genetic and clinical heterogeneity. Methods: We performed Treg-cell–specific epigenetic quantification and immunologic characterization of severe “typical” (n = 6) and “atypical” or asymptomatic (n = 9) patients with IPEX. Results: Increased number of cells with Treg-cell–Specific Demethylated Region demethylation in FOXP3 is a consistent feature in patients with IPEX, with (1) highest values in those with typical IPEX, (2) increased values in subjects with pathogenic FOXP3 but still no symptoms, and (3) gradual increase over the course of disease progression. Large-scale profiling using Luminex identified plasma inflammatory signature of macrophage activation and TH2 polarization, with cytokines previously not associated with IPEX pathology, including CCL22, CCL17, CCL15, and IL-13, and the inflammatory markers TNF-α, IL-1A, IL-8, sFasL, and CXCL9. Similarly, both Treg-cell and Teff compartments, studied by Mass Cytometry by Time-Of-Flight, were skewed toward the TH2 compartment, especially in typical IPEX. Conclusions: Elevated TSDR-demethylated cells, combined with elevation of plasmatic and cellular markers of a polarized type 2 inflammatory immune response, extends our understanding of IPEX diagnosis and heterogeneity.
KW - CD4 Teff
KW - CyTOF
KW - FOXP3
KW - T2
KW - TSDR demethylation
KW - Treg cells
KW - atypical IPEX
KW - cytokines
KW - epigenetic
KW - typical IPEX
UR - http://www.scopus.com/inward/record.url?scp=85140394380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140394380&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2022.09.013
DO - 10.1016/j.jaci.2022.09.013
M3 - Article
C2 - 36152823
AN - SCOPUS:85140394380
SN - 0091-6749
VL - 151
SP - 233-246.e10
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -